MENU
+Compare
KVUE
Stock ticker: NYSE
AS OF
Apr 9 closing price
Price
$21.78
Change
+$0.29 (+1.35%)
Capitalization
40.65B

KVUE Kenvue Forecast, Technical & Fundamental Analysis

Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue... Show more

KVUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KVUE with price predictions
Apr 09, 2025

KVUE in +2.04% Uptrend, advancing for three consecutive days on March 31, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where KVUE advanced for three days, in of 95 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

KVUE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on KVUE as a result. In of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KVUE turned negative on March 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 13 similar instances when the indicator turned negative. In of the 13 cases the stock turned lower in the days that followed. This puts the odds of success at .

KVUE moved below its 50-day moving average on April 04, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KVUE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KVUE entered a downward trend on April 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.626) is normal, around the industry mean (17.160). P/E Ratio (23.589) is within average values for comparable stocks, (204.360). Projected Growth (PEG Ratio) (2.337) is also within normal values, averaging (3.832). Dividend Yield (0.028) settles around the average of (0.107) among similar stocks. P/S Ratio (2.543) is also within normal values, averaging (115.095).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KVUE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KVUE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

View a ticker or compare two or three
KVUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KVUE is expected to report earnings to rise 15.38% to 30 cents per share on May 13

Kenvue KVUE Stock Earnings Reports
Q1'25
Est.
$0.30
Q4'24
Missed
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$0.32
Q1'24
Est.
$0.28
The last earnings report on February 06 showed earnings per share of 25 cents, missing the estimate of 31 cents. With 22.04M shares outstanding, the current market capitalization sits at 40.65B.
A.I.Advisor
published Dividends

KVUE paid dividends on February 26, 2025

Kenvue KVUE Stock Dividends
А dividend of $0.20 per share was paid with a record date of February 26, 2025, and an ex-dividend date of February 12, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry HouseholdPersonalCare

Profile
Fundamentals
Details
Industry
N/A
Address
199 Grandview Road
Phone
+1 908 874-1200
Employees
22000
Web
https://www.kenvue.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
H119.1614.89
+14.28%
Hyatt Hotels Corp
CBL23.951.53
+6.82%
CBL & Associates Properties
LIVN35.721.87
+5.52%
LivaNova PLC
INTT6.060.25
+4.30%
inTEST Corp
PMCB1.210.01
+0.42%
PharmaCyte Biotech

KVUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KVUE has been loosely correlated with CL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if KVUE jumps, then CL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KVUE
1D Price
Change %
KVUE100%
+0.05%
CL - KVUE
46%
Loosely correlated
+1.84%
KMB - KVUE
38%
Loosely correlated
+1.40%
PG - KVUE
36%
Loosely correlated
+2.48%
CHD - KVUE
33%
Poorly correlated
+0.31%
CLX - KVUE
29%
Poorly correlated
+2.51%
More

Groups containing KVUE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KVUE
1D Price
Change %
KVUE100%
+0.05%
Household/Personal Care
industry (78 stocks)
33%
Poorly correlated
+2.18%